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ABSTRACT Intestinal epithelial cells (IECs) are exposed to profound fluctuations in oxygen 
tension and have evolved adaptive transcriptional responses to a low-oxygen environment. 
These adaptations are mediated primarily through the hypoxia-inducible factor (HIF) com-
plex. Given the central role of the IEC in barrier function, we sought to determine whether 
HIF influenced epithelial tight junction (TJ) structure and function. Initial studies revealed that 
short hairpin RNA–mediated depletion of the HIF1β in T84 cells resulted in profound defects 
in barrier and nonuniform, undulating TJ morphology. Global HIF1α chromatin immunopre-
cipitation (ChIP) analysis identified claudin-1 (CLDN1) as a prominent HIF target gene. Analy-
sis of HIF1β-deficient IEC revealed significantly reduced levels of CLDN1. Overexpression of 
CLDN1 in HIF1β-deficient cells resulted in resolution of morphological abnormalities and 
restoration of barrier function. ChIP and site-directed mutagenesis revealed prominent 
hypoxia response elements in the CLDN1 promoter region. Subsequent in vivo analysis re-
vealed the importance of HIF-mediated CLDN1 expression during experimental colitis. These 
results identify a critical link between HIF and specific tight junction function, providing im-
portant insight into mechanisms of HIF-regulated epithelial homeostasis.
INTRODUCTION
The epithelium of the gastrointestinal tract serves as a selective bar-
rier between the host and luminal antigens. Defects in barrier func-
tion have been linked to many human diseases, most notably 
inflammatory bowel diseases such as Crohn’s disease and ulcerative 
colitis (McGuckin et al., 2009). The barrier is maintained by cell–cell 
interactions known as tight junctions, which serve to seal the epithe-
lial monolayer (Ivanov, 2012). Tight junctions are composed of both 
cytosolic (i.e., zonula occludins) and integral membrane proteins 
(i.e., occludin, claudins). Claudins are a large family of tetraspanning 
integral membrane proteins uniquely responsible for the selective 
permeability of tight junctions (Van Itallie and Anderson, 2013) and 
can be categorized as “leaky” or “tight” with regard to their effect 
on barrier function (Anderson et al., 2004; Anderson and Van Itallie, 
2009). Claudin-1 (CLDN1) is an important “tight” claudin and has 
been shown to be dysregulated in a variety of human diseases, in-
cluding inflammatory bowel disease (Kucharzik et al., 2001; Weber 
et al., 2008).
The epithelium of the gut is a unique metabolic environment. 
Intestinal epithelial cells are exposed to the anoxic lumen at the api-
cal aspect and a highly vascularized submucosa on the basolateral 
side, resulting in a steep oxygen gradient across the mucosa. 
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hypoxia response element (HRE) consensus sequences, and ChIP 
and promoter studies confirm CLDN1 as a transcriptional target of 
HIF. These findings link HIF to barrier function at the level of the 
tight junction itself and shed further light on the mechanism of the 
profound barrier-protective effects of HIF signaling.
RESULTS
Depletion of HIF1β in human IECs results in barrier defects
HIF has been integrally linked to barrier function in intestinal epithe-
lial cells through a number of genes important in innate immune de-
fense in vitro and in vivo (Colgan and Taylor, 2010; Glover and 
Colgan, 2011). However, no direct associations have been made be-
tween HIF and epithelial tight junction (TJ) proteins. To determine 
the relative contribution of HIF to TJ integrity and function, we used 
short hairpin RNA (shRNA)–mediated knockdown to deplete the 
common HIF1β subunit in T84 and Caco2 human intestinal epithelial 
cells. HIF1β knockdown (KD) resulted in significant reduction in HIF1β 
mRNA (65 ± 9%, p < 0.01) as compared with short-hairpin nontarget-
ing controls (shNTC) as measured by RT-PCR. With this strategy, 
HIF1β protein was undetectable by Western blot (Figures 1, A and B).
TJ integrity was measured by transepithelial resistance (TER) us-
ing polarized T84 monolayers grown on membrane-permeable sup-
ports. HIF1β KD resulted in a significant reduction (80 ± 4% de-
creases, p < 0.01) in TER as compared with shNTC (Figure 1C). 
Furthermore, a comparison of flux rates of various-sized fluorescein 
isothiocyanate (FITC)–dextrans revealed major deficits in paracellu-
lar permeability in cells lacking HIF1β. Significant differences in 
paracellular permeability were seen over a range of molecular sizes, 
including 3 kDa (Stokes radius 17 Å, p < 0.05), 10 kDa (Stokes radius 
23 Å, p < 0.001), and 40 kDa (Stokes radius 44 Å, p < 0.01; 
Therefore intestinal epithelial cells at baseline reside in a state of 
much lower oxygen tension than elsewhere in the body, termed 
“physiologic hypoxia” (Karhausen et al., 2004). This hypoxic micro-
environment leads to stabilization of the hypoxia-inducible factor 
(HIF) complex, a transcription factor comprised of an oxygen-labile 
α subunit and constitutively expressed β subunit that plays a central 
role in epithelial cell function and homeostasis. HIF signaling has 
been linked extensively to barrier function through transcriptional 
control of intestinal trefoil factor (Furuta et al., 2001), multidrug re-
sistance gene (Comerford et al., 2002), mucin-3 (Louis et al., 2006), 
and CD73 (Synnestvedt et al., 2002) and has been shown to be pro-
tective in murine models of colitis (Karhausen et al., 2004; Cummins 
et al., 2008; Robinson et al., 2008). The profound barrier-protective 
effects of HIF signaling have been attributed to regulation of tissue 
integrity through adenosine signaling, antimicrobial peptides, and 
modulation of the mucus layer (Kelly et al., 2012, 2013). No direct 
link has been made between HIF and expression or localization of 
tight junction components.
In this study, we define a central role for HIF signaling in junc-
tional integrity and homeostasis. Knockdown of HIF1β in vitro re-
sulted in significant defects in barrier function, as well as in gross 
morphological abnormalities in the architecture of the tight junc-
tion. Screening of tight junction proteins by chromatin immunopre-
cipitation (ChIP)-on-chip highlighted CLDN1 as a potential HIF tar-
get. We show significant repression of CLDN1 in HIF1β-deficient 
intestinal epithelial cells (IECs) by quantitative reverse transcriptase 
PCR (RT-PCR) and Western blot analysis. Reintroduction of CLDN1 
into HIF1β-deficient Caco2 cells resulted in resolution of morpho-
logical abnormalities and reversal of defects in paracellular barrier 
function. Finally, analysis of the CLDN1 promoter revealed multiple 
FIGURE 1: Influence of HIF1β KD on intestinal epithelial cell tight junction structure and function. (A) Lentiviral 
shRNA–mediated KD of HIF1β in T84 intestinal epithelial cells results in reduced HIF1β mRNA relative to shNTC. 
(B) HIF1β KD results in loss of HIF1β protein in both normoxia and hypoxia. (C) TER measurements reveal significant 
transcellular barrier defects in HIF1β KD T84 cells. Data represented as fold of shNTC TER. (D) FITC-dextran flux assay 
of HIF1β KD T84 cells reveal significant defects in paracellular permeability even with high–molecular weight FITC-
dextran. (E) Immunofluorescence for ZO1 in HIF1β KD T84 cells reveals profound morphological abnormalities at the 
level of the tight junction. (F) Top, representative confocal images showing the distribution of TJ-associated ZO1 in 
shNTC and HIF1β KD T84 cells, as represented in x-z views (apical to basolateral). Bottom, representative confocal 
images showing detailed colocalization of ZO1 and F-actin at apical junctions and diminished F-actin labeling of HIF1β 
KD lateral cell membranes. Error bars represent SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 as determined by 
Student’s t test. Scale bars, 10 μm. In all cases, n = 3 independent experiments.
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HIF1β resulted in decreased intensity of subapical phalloidin stain-
ing, correlating with lateral membrane loss and reduced cell size. 
Taken together, these results strongly implicated HIF signaling as a 
critical determinant of TJ architecture, integrity, and membrane 
assembly.
ChIP-on-chip analysis identifies CLDN1 as an HIF target
To identify the existence of candidate HIF targets within the TJ, a 
ChIP-on-chip promoter analysis was performed and screened for 
binding to HIF1α as previously described (Glover et al., 2013; avail-
able through the Gene Expression Omnibus database, accession 
no. GSE43108). Briefly, ChIP was performed on Caco2 IECs with 
HIF1α-specific polyclonal antibody. ChIP-enriched samples were 
then hybridized to a custom microarray. Significantly enriched tar-
gets included many known HIF targets, including BNIP3L (Sowter 
et al., 2001; Figure 2A). Of the TJ promoters tiled on the array, only 
CLDN1 showed significant enrichment for binding to HIF1α (p < 
0.001; Figure 2A).
As an extension of these ChIP-on-chip findings, we validated 
the specific regulation of CLDN1 by HIF in HIF1β KD cells. RT-
PCR revealed significantly attenuated expression of CLDN1 
mRNA in HIF1β KD T84 cells (59 ± 10% reduction in CLDN1 
mRNA, p < 0.001; Figure 2B). No significant differences were ob-
served by RT-PCR in other well-characterized claudins or in bar-
rier-regulating TJ (ZO1, occludin, JAM-A) or adherens junction 
(AJ; E-cadherin) components (Table 1). Western blotting of cell 
Figure 1D). These data strongly suggest that HIF is a critical deter-
minant in formation and subsequent maintenance of epithelial bar-
rier function.
Loss of HIF signaling results in morphological abnormalities 
of TJs
In light of the severe functional barrier defects observed in HIF1β 
KD cells and our recent observation that HIF KD results in defective 
TJ morphology (Glover et al., 2013), we examined the integrity of 
TJs in HIF1β KD. Here we visualized the TJ marker zonula occludens 
1 (ZO1) by immunofluorescence in confluent shNTC and HIF1β KD 
T84 monolayers. This analysis revealed the typical chicken-wire pat-
terns of ZO1 staining in shNTC cells, with linear ZO1 contacts be-
tween cells and an even distribution of ZO1 throughout cell–cell 
junctions (Figure 1E). By stark contrast, confluent HIF1β KD mono-
layers showed dramatic morphological abnormalities characterized 
by pronounced undulations of ZO1 visualized in the apical lateral 
membrane. Moreover, ZO1 was unevenly dispersed throughout the 
junction, giving the junctions a more beaded appearance (Figure 
1E). These abnormalities in TJ structure were not unique to T84 
cells, as HIF1β KD in Caco2 cells resulted in similar changes to TJ 
structure. Given the aberrant morphology of HIF1β KD intercellular 
junctions, we next considered whether HIF1β depletion similarly 
conferred gross changes in polarized cell height. Phalloidin staining 
was used to label cytoskeletal F-actin in apical perijunctional regions 
and lateral membrane cortices. As outlined in Figure 1F, loss of 
FIGURE 2: Claudin-1 expression in HIF1β KD T84 cells. (A) HIF ChIP-on-chip highlights CLDN1 as a potential HIF target. 
Hatched bar represents a positive control (BNIP3L). Bar graph represents log2-fold enrichment of ChIP DNA relative to 
input chromatin. (B) RT-PCR analysis of HIF1β KD T84s reveals significant repression of CLDN1 mRNA relative to shNTC. 
(C) Western blotting indicates loss of CLDN1 expression, as quantified by densitometry. (D) T84 shNTC and HIF1β KD 
cells were fixed and immunostained for CLDN1 (green) and F-actin (phalloidin; red). Representative confocal images 
were taken of perijunctional actomyosin ring at apical junctions of cells, showing significantly diminished junctional 
CLDN1 staining. The localization of CLDN1 and F-actin along the z-axis of cells is represented in x-z views (apical to 
basolateral). Arrowheads indicate enrichment of CLDN1 and F-actin at apical cell–cell contacts. CLDN1 staining and 
F-actin immunodecoration of apical and cytoskeletal cortices revealed loss of lateral membrane and cellular 
height.*p < 0.05 and ***p < 0.001 as determined by Student’s t test. In all cases, n = 3 independent experiments.
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knockdown IEC monolayers. CLDN1 staining was prominently de-
creased both at cell–cell contacts and within lateral membranes of 
HIF1β-knockdown IECs as compared with controls, with heteroge-
neous redistribution of CLDN1 to apical clusters in a subset of cells. 
Of interest, loss of lateral CLDN1 in HIF1β-knockdown IECs corre-
lated with a reduction in lateral membrane length and cell height, as 
evaluated by F-actin immunostaining (Figure 2D). Further, the lateral 
distribution of F-actin fluorescence across cell–cell contacts was di-
minished in HIF1β-knockdown IECs compared with shNTC controls, 
despite the fact that total cellular levels of actin were not altered.
Dynamics of CLDN1 expression during IEC 
barrier establishment
We next determined whether HIF contributed to barrier assembly. 
To explore this, shNTC and HIF1β KD T84 cells were incubated in 
low-Ca2+ medium overnight to disassemble the junctional com-
plex, then returned to high-Ca2+ medium (i.e., Ca2+ switch assay). 
TERs were monitored to determine the rate of barrier recovery. 
HIF1β KD T84 cells had significantly decreased resistances after 
24 h relative to shNTC (Figure 3A). No major differences in the rate 
of TER recovery after Ca2+ switch were observed. Protein was har-
vested before Ca2+ switch (t = −24 h), upon return to high-Ca2+ 
medium (t = 0 h), and after recovery (t = 24 h). Western blot analysis 
revealed a slight increase in CLDN1 in both shNTC and HIF1β KDs 
at t = 0bh, followed by a decrease to baseline conditions in recov-
ered monolayers (Figure 3B). RT-PCR demonstrated no significant 
induction of CLDN1 at t = 0 h. These data suggest that whereas 
HIF1β KD IECs harbor baseline defects in TJ structure and function, 
the apical junction reassembly response as measured by Ca2+ 
switch is not significantly affected by the loss of HIF1-dependent 
CLDN1 expression.
Selective depletion of CLDN1 recapitulates aberrant TJ 
morphology of HIF1β KD epithelia
We next sought to examine whether selective knockdown of CLDN1 
could recapitulate the phenotype of HIF1β-depleted T84 IECs. Sta-
ble knockdown of CLDN1 using lentiviral shRNA particles resulted 
in significant repression of CLDN1 mRNA and protein levels, re-
spectively, relative to shNTC control cells (Figure 4, A and B). Of 
importance, CLDN1 depletion relative to 
shNTC controls was found to be similar be-
tween CLDN1 KD (74 ± 10%, p < 0.01) and 
HIF1β KD T84 IECs (65 ± 9%, p < 0.01). In 
contrast to HIF1β-depleted IECs, no signifi-
cant changes were detected in TER values 
(Figure 4C) or in permeability to 3-kDa 
FITC-dextran in polarized CLDN1 KD IECs 
compared with shNTC monolayers (Supple-
mental Figure S1). This finding is consistent 
with previous work that found little effect of 
transient siRNA-mediated CLDN1 knock-
down on barrier function in model IEC 
monolayers (Mrsny et al., 2008).
To analyze TJ morphology in CLDN1 KD 
T84 IECs, we performed ZO1 immunofluo-
rescence staining and confocal microscopy. 
As outlined in Figure 4, D and E, the mor-
phological characteristics of CLDN1-de-
pleted IECs closely resembled those of 
HIF1β KD cells, namely undulating apical 
lateral membranes and increased cell area 
relative to shNTC control monolayers.
lysates showed a nearly complete loss of CLDN1 in HIF1β KD 
cells (80 ± 7% decrease relative to shNTC as measured by densi-
tometry; p < 0.05; Figure 2C).
Of note, this observation of HIF-dependent CLDN1 expression 
was not unique to T84 cells. Indeed, HIF1β depletion in Caco2 epi-
thelial cells confirmed this phenotype. It is also remarkable that no 
differences in CLDN1 expression were noted between normoxic 
and hypoxic cells by either RT-PCR or Western blot, suggesting a 
role for basal HIF signaling in the maintenance and expression of 
CLDN1.
Immunolocalization studies have indicated an association of 
CLDN1 both with apical TJs and along the lateral plasma mem-
brane in polarized epithelia (Nunbhakdi-Craig et al., 2002; 
Marchiando et al., 2010). To interrogate whether junctional or lateral 
CLDN1 populations are selectively depleted in HIF1β-knockdown 
IECs, we compared CLDN1 localization in shNTC control and HIF1β-
Name Fold change SEM Significance
CLDN1 0.41 0.09 p < 0.001
CLDN2 1.53 0.75 ns
CLDN3 1.12 0.22 ns
CLDN4 1.56 0.39 ns
CLDN5 1.5 0.92 ns
CLDN6 0.83 0.08 ns
CLDN7 0.77 0.09 ns
CLDN10 1.55 0.62 ns
CLDN15 1.01 0.31 ns
CLDN18 1.32 0.71 ns
ZO1 0.971 0.173 ns
Occludin 1.44 0.29 ns
JAM-A 1.45 0.36 ns
E-cadherin 1.07 0.28 ns
TABLE 1: Expression of TJ and AJ components in HIF1β KD T84 cells.
FIGURE 3: Expression and function of CLDN1 in HIF1β KD epithelia during barrier assembly. 
(A) shNTC and HIF1β KD T84 cells were subjected to Ca2+ switch, and TER was monitored over 
time. (B) Western blotting at various time points revealed a slight increase in CLDN1 expression 
at t = 0 and then repression at t = 24 in both shNTC and HIF1β KD. (C) RT-PCR analysis indicates 
no increase in transcript at t = 0, with a significant decrease in transcript at t = 10. *Relative to 
shNTC, #relative to shNTC, t = 0. *p < 0.05, **p < 0.01, and ***p < 0.001 as determined by 
Student’s t test. In all cases, n = 3 independent experiments.
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Figure 5A, increasing concentrations of CLDN1 plasmid resulted in 
nearly complete normalization of TJ morphology. The abnormal un-
dulations and punctate ZO1 staining were lost in cells transfected 
with CLDN1 plasmid, and distribution of ZO1 was more uniform 
than in mock-transfected cells. Quantification of junctional length 
relative to a straight line between tricellular junctions (TJ length ra-
tio, analysis depicted in Figure 5B) revealed a dose-dependent nor-
malization of the apical lateral membrane in the presence of CLDN1 
(Figure 5C, p < 0.001). Western blotting of transfected cells con-
firmed that CLDN1 levels were increased in a dose-dependent 
manner (Figure 5D). To determine whether heterologous expression 
of CLDN1 could rescue the barrier defect of the HIF1β-deficient 
cells, cells were transfected with 5 or 10 μg of CLDN1 expression 
plasmid, seeded on permeable inserts, and grown to confluence. 
FITC-dextran flux revealed a significant decrease in paracellular per-
meability in transfected monolayers at both plasmid concentrations 
Analysis of myosin motor phosphorylation (pMLC) revealed no 
changes in KD T84 lysates relative to shNTC cells, suggesting that 
morphological abnormalities in CLDN1 and HIF1β KD IECS are not 
manifested through altered signaling at the level of the cortical ac-
tomyosin belt.
Heterologous expression of CLDN1 in HIF1β KD rescues 
morphological abnormalities
To investigate the influence of CLDN1 in the context of nascent 
junction integrity, we transfected a human CLDN1 expression plas-
mid at two concentrations (5 and 10 μg) into subconfluent HIF1β-
deficient Caco2 cells. At 24 h posttransfection, the cells were lifted 
and concentrated onto membrane-permeable supports and 
localized for TJ structure. Immunofluorescence analyses 48 h post-
transfection revealed a CLDN1 dose–dependent recovery of normal 
TJ morphology, as measured by ZO1 localization. As shown in 
FIGURE 4: Claudin-1 depletion influences intestinal epithelial cell size and architecture. (A) Stable shRNA-mediated 
knockdown of CLDN1 in T84 intestinal epithelial cells significantly depletes endogenous CLDN1 mRNA levels relative to 
shNTC. (B) Western blotting confirms loss of CLDN1 protein expression. (C) TER measurements in shNTC, CLDN1 KD, 
and HIF1β KD T84 cells. Data are represented as fold change relative to shNTC TER. (D) Confluent shNTC and 
knockdown T84 monolayers were fixed and immunostained for ZO1. Representative x-y confocal images of apical ZO1 
distribution reveal TJ morphological irregularities in CLDN1 KD and HIF1β KD T84 cells. (E) Distribution of epithelial size 
was quantified by measuring relative cell area in shNTC, CLDN1 KD, and HIF1β KD T84 cell confocal images as 
represented in D. Results depict reduced uniformity of KD junctional profiles and increased cell size (fourfold) relative to 
shNTC control IECs. Data are represented as means (400 cells). *p < 0.05 and **p < 0.01 as determined by Student’s 
t test. In all cases, n = 3 independent experiments.
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promoter activity relative to an empty vector control, (7.6 ± 1.9)-
fold (p < 0.05).
We further extended these studies to define a role for HIF in 
CLDN1 promoter activity. To do this, we mutated the two putative 
HRE consensus sequences (from 5′-GCGTG-3′ to 5′-GTTCG-3′) and 
analyzed them by luciferase assay. As shown in Figure 7B, mutation 
of the distal HRE 2 site (position −590) did not influence activity rela-
tive to wild-type plasmid. By contrast, mutation of the proximal HRE 
1 site (position −226) resulted in a significant decrease in luciferase 
activity (65 ± 11% decrease relative to wild type, p < 0.05), strongly 
indicating an important role for the HRE 1 site in HIF-dependent 
regulation of CLDN1 promoter activity.
CLDN1 expression in HIF1β intestinal epithelial–specific 
knockout mice
Given the profound TJ phenotype observed in HIF1β KD cells in 
vitro, we sought to determine the relevance of HIF signaling in 
CLDN1 expression and barrier function in vivo. Here we profiled 
CLDN1 expression in the proximal and distal intestine using muco-
sal scrapings from conditional IEC Hif1β-knockout mice. As shown in 
Figure 8A, this analysis revealed selective repression of CLDN1 
mRNA in the duodenum of conditional IEC Hif1β KOs relative to 
control (53 ± 8%, p < 0.05). No baseline differences in CLDN1 
mRNA were observed in colonic mucosa (Figure 8A).
Barrier function in these conditional IEC Hif1β KO animals was 
previously assessed using FITC-dextran permeability. No differ-
ences were observed between control and HIF1β KO animals at 
baseline (Glover et al., 2013). Induction of experimental colitis using 
either dextran sodium sulfate or trinitrobenzene sulfonic acid 
(TNBS), however, resulted in significantly enhanced barrier defects 
in HIF1β KO animals relative to controls (Glover et al., 2013). Thus 
(p < 0.001; Figure 5E). Western blot analysis confirmed increased 
levels of CLDN1 in transfected monolayers relative to controls 
(Figure 5F). These results identify a critical function for CLDN1 in the 
formation of the nascent TJ in HIF1β-deficient cells. Moreover, 
these data implicate a central role for HIF-dependent CLDN1 ex-
pression in normal TJ structure of IEC.
HIF1 binds and regulates the CLDN1 promoter
To gain insight into the mechanism of HIF-dependent CLDN1 ex-
pression, we examined whether HIF regulates the CLDN1 promoter. 
Analysis of the full-length promoter region of human CLDN1 (Kramer 
et al., 2000) revealed two HRE consensus sequences located at posi-
tions −226 (HRE 1) and −590 (HRE 2) relative to the transcription start 
site (Figure 6A). HIF1α and HIF2α ChIP was performed in Caco2 
cells, and PCR analysis spanning the putative HRE sites demon-
strated significant enrichment for both HRE sequences in the CLDN1 
promoter relative to an immunoglobulin G (IgG) control (Figure 6, 
B–E). Of note, CLDN1 promoter enrichment on HIF1α increased in 
response to 6 h of hypoxia (1% O2), whereas enrichment diminished 
on HIF2α under hypoxic conditions. Moreover, these results indicate 
that both HIF1α and HIF2α are actively bound to the promoter of 
CLDN1 under normoxic and hypoxic conditions.
To define further the role of HIF and the HRE consensus se-
quences on CLDN1 expression, we used a CLDN1 promoter—a 
luciferase reporter plasmid containing 728 base pairs of the 
CLDN1 promoter proximal to the transcription start site. To define 
the role of HIF in promoter regulation, we cotransfected CLDN1 
reporter plasmids into Caco2 cells with constitutively active HIF1α 
or HIF2α overexpression plasmids as described previously (Glover 
et al., 2013). As shown in Figure 7A, overexpression of either 
HIF1α or HIF2α resulted in a significant induction of CLDN1 
FIGURE 5: Tight junction morphology of HIF1β KD after heterologous expression of CLDN1. (A) Immunofluorescence 
for ZO1 in HIF1β KD Caco2 cells transfected with empty vector reveals characteristic junctional abnormalities. 
Transfection with 5 or 10 μg of CLDN1 expression plasmid resulted in normalization of ZO1 distribution and loss of 
membrane undulations as visualized by immunofluorescence. (B) Quantification of undulations was performed by 
dividing the actual junction length by the distance between tricellular junctions. Examples of abnormal (left) and normal 
(right) TJ localization by ZO-1 immunofluorescence. (C) TJ length ratio analysis revealed a dose-dependent improvement 
in junctional length ratio. (D) Western blotting of transfected lysates confirms a dose-dependent increase in CLDN1 
expression 48 h posttransfection. (E) FITC-dextran flux assay demonstrated a significant, dose-dependent decrease in 
paracellular permeability in CLDN1-transfected HIF1β KD Caco2 monolayers. (F) Western blot analysis confirms 
heterologous CLDN1 expression at day 7 posttransfection. Results are presented as mean ± SEM ratio. *p < 0.05 and 
***p < 0.001 as determined by Student’s t test. Scale bars, 10 μm.
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we compared CLDN1 expression in these 
mouse lines after induction of TNBS colitis 
(Figure 8B). RT-PCR analysis of mucosal 
scrapings for CLDN1 in tissues obtained 
from these mice tracked with the observed 
phenotype. Indeed, vehicle-treated mice 
showed no difference in CLDN1. Induction 
of colitis, however, resulted in a significant 
repression of CLDN1 in HIF1β KO mice rela-
tive to controls (p < 0.05; Figure 8B). Previ-
ous studies using HIF-overexpressing mice 
showed that a number of HIF targets are not 
induced at baseline but are induced during 
an inflammatory insult (Karhausen et al., 
2004). CLDN1 does not appear to be in-
duced in a similar manner but is instead 
maintained at homeostatic levels during 
colitis. Similarly, vehicle-treated conditional 
HIF1β KO mice exhibited no significant 
change in either mucosal occludin or E-cad-
herin expression compared with wild-type 
vehicle controls, strongly arguing against 
global compensatory changes in these junc-
tion components in this model (Figure 8C). 
Taken together, these results suggest that 
loss of IEC HIF signaling directly disrupts 
barrier maintenance and enhances the per-
meability of the intestinal epithelium during 
experimental colitis.
DISCUSSION
The intestinal mucosa is composed of a sin-
gle layer of columnar epithelium that serves 
as a selective barrier to ever-present luminal 
antigens. Critical to this barrier function are 
cell–cell contacts known as TJs, which pro-
vide a paracellular seal in epithelial tissues 
(Hartsock and Nelson, 2008). A key compo-
nent of these junctional complexes is 
CLDN1, an integral membrane protein that 
mediates interactions between neighboring 
cells and cytosolic tight junction proteins 
(McCarthy et al., 2000; Cording et al., 2013). 
A so-called “tight claudin,” CLDN1 plays an 
integral role in determining barrier function 
in IECs (Inai et al., 1999) and is a marker of 
differentiation in the squamous epithelium 
of the esophagus. Despite its importance, 
little is known about the transcriptional reg-
ulation of CLDN1.
Here we identify HIF as a central tran-
scriptional regulator of CLDN1. Using 
shRNA-mediated knockdown of HIF1β in 
T84 intestinal epithelial cells, we observed 
significant defects in barrier function. More-
over, depletion of HIF1β resulted in pro-
found morphological abnormalities at the 
level of the tight junction, characterized by 
uneven distribution of ZO1 and irregular un-
dulations at the level of the TJ. This mor-
phology is reminiscent of our recent work 
revealing that knockdown of HIF-2α and 
FIGURE 6: Binding of HIF1α to the CLDN1 promoter. (A) Promoter analysis of CLDN1 
highlights two potential HRE consensus sequences proximal to the transcription start site. 
ChIP for HIF1α followed by PCR using primers spanning (B) HRE 2 and (C) HRE 1 reveals 
significant enrichment of the CLDN1 promoter in both normoxia and hypoxia. Error bars 
represent SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 as determined by Student’s t test. 
Three independent experiments.
FIGURE 7: Influence of HIF1α on function the CLDN1 promoter. (A) Cotransfection of CLDN1 
luciferase reporter plasmid with HIF1α overexpression plasmid containing a mutated oxygen-
dependent degradation domain resulted in significant increase in CLDN1 promoter activity 
relative to empty vector (EV). (B) Mutagenesis of HRE 2 did not significantly affect basal 
promoter activity. However, mutagenesis of HRE 1 resulted in a significant decrease in this 
activity, pointing to its importance in basal regulation of the CLDN1 promoter. Results are 
presented as mean ± SEM ratio. *p < 0.05 as determined by Student’s t test. In all cases, n = 3 
independent experiments.
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FIGURE 8: In vivo analysis of HIF regulation of CLDN1. (A) RT-PCR from mucosal scrapings 
obtained from conditional HIF1β intestinal epithelial KO mice (M. musculus) reveals significant 
repression of CLDN1 in the duodenum but no difference in the colons of healthy mice. 
(B) RT-PCR for CLDN1 after induction of TNBS colitis reveals no difference between WT and 
HIF1β KO mice in vehicle-treated control colon (3–5 mice/genotype). Treatment with TNBS, 
however, resulted in a significant difference between WT and KO mice (10–15 mice/genotype). 
(C) Quantitative PCR for the TJ molecule occludin and adherens junction–associated E-cadherin 
in wild-type and HIF1β KO mice colonic samples. No change in mucosal occludin or E-cadherin 
was detected in vehicle-treated cohorts. TNBS challenge resulted in repression of occludin in 
wild-type but not HIF1β KO mice. Results are presented as mean ± SEM; *p < 0.05.
inhibition of creatine kinase (CK) resulted in junctional defects simi-
lar to those observed here with HIF1β (Glover et al., 2013). Such 
changes in CK expression were mapped to defects in functional en-
ergetic coupling between the adherens junction and the actomyo-
sin ring, where CK likely constitutes one terminal of a functional 
phosphocreatine/creatine kinase energy circuit that supplies energy 
to myosin motors. Similar structural abnormalities to TJ strand mor-
phology, including the beaded appearance and lateral undulations, 
were originally observed in RhoA and Rac1 mutants (Jou et al., 
1998) and defined important roles for GTPase signaling in spatial 
organization of TJ proteins. Of interest, RhoA has been implicated 
at multiple levels in the stabilization of HIF1 (Turcotte et al., 2003, 
2004; Pacary et al., 2007; Vogel et al., 2010), suggesting that these 
original observations of abnormal TJ formation in RhoA mutants 
could be mediated, at least in part, by aberrant HIF stabilization.
Guided by a HIF ChIP-on-chip promoter array, we identified 
CLDN1 as a potential HIF target gene. A specific enrichment of 
CLDN1 within the claudin family of genes provided insight into the 
junctional defects observed in HIF1β KD IEC. Previous studies with 
the CLDN1 promoter revealed the relative importance for the pro-
moter SP1 site in butyrate-induced expression of CLDN1 (Wang 
et al., 2012). Similarly, Lopardo et al. (2008). showed that p63 binds 
to the CLDN1 promoter and regulates keratinocyte development. 
Our analysis of the CLDN1 promoter revealed a functional HRE site 
(position −226) that was relatively more important than another HRE 
consensus located upstream (position −590). It is noteworthy that 
CLDN1 was not hypoxia inducible per se; instead, these results sug-
gest that basal levels of stabilized HIF tonally regulate homeostatic 
levels of CLDN1. This is not unprecedented. For example, we re-
cently demonstrated that IEC human β-defensin-1 expression is 
regulated through similar mechanisms in-
volving constitutive HIF stabilization under 
conditions of “physiologic hypoxia” (Kelly 
et al., 2013). Such observations stem from 
the steep oxygen gradient that exists from 
the anaerobic lumen of the intestine across 
the epithelium to the highly vascularized 
subepithelium (Colgan and Taylor, 2010). 
From this perspective, it is perhaps not sur-
prising that the epithelium has evolved a 
number of features to cope with this meta-
bolic setting. Studies comparing functional 
responses between epithelial cells from dif-
ferent tissues have revealed that IEC appear 
to be uniquely resistant to hypoxia (Furuta 
et al., 2001) and that low levels of oxygen-
ation within the normal intestinal epithelial 
barrier (i.e., “physiologic hypoxia”) may be 
a regulatory adaptation that could control 
some target genes (e.g., CLDN1) through 
basal HIF stabilization. The extent to which 
this observation might differ between the 
colonic mucosa and other more oxygenated 
tissue beds remains unclear.
The most striking observation from this 
work was the normalization of TJ morphol-
ogy and function through heterologous ex-
pression of CLDN1 in HIF1β-deficient cells. 
This finding strongly implies a central role 
for HIF-regulated CLDN1 expression in nor-
mal TJ dynamics. Of interest, selective 
knockdown of CLDN1 in IECs alters TJ 
shape and linearity, whereas TER and paracellular flux remain unaf-
fected. As such, the expression of other claudins by T84 IECs likely 
contributes to TJ barrier function, analogous to observations in 
other model intestinal epithelia (Mrsny et al., 2008). Given the es-
tablished role of HIF as a global regulator of IEC barrier function and 
homeostasis, it is perhaps unsurprising that HIF1β knockdown re-
sults in more profound attenuation of barrier properties than indi-
vidual CLDN1 depletion. It is likely that additional transcriptional 
targets remain to be identified and that coordinated regulation of 
such targets confers pleotropic effects on barrier function. Indeed, 
based on our finding that CLDN1 knockdown recapitulates the mor-
phological aberrations but not the barrier deficits of HIF-depleted 
cells, it is plausible that compensatory pathways engaged in the 
setting of CLDN1 deficiency are themselves subject to HIF regula-
tion. Moreover, heterotypic interactions between claudin family 
members have been identified in epithelial apical junctions (Furuse 
et al., 1999; Mrsny et al., 2008), suggesting that claudin species 
other than CLDN1 can readily contribute to TJ function and paracel-
lular flux in intestinal epithelia. Nonetheless, our findings of altered 
TJ morphology in CLDN1 KD IECs, coupled with restoration of TJ 
linearity upon heterologous CLDN1 expression in HIF1 β KD IECs, 
clearly argues for a critical role of HIF signaling in constitutive 
CLDN1 regulation.
Little is known about the role of CLDN1 in establishing and/or 
maintaining intestinal epithelial shape and size. Seminal work by 
Furuse and Tsukita demonstrated that ectopic expression of 
CLDN1 and CLDN2 in nonepithelial cells could recapitulate TJ-like 
freeze fracture strands, indicating that these claudins are largely 
responsible for TJ strand formation (Furuse et al., 1998). Analysis 
of discrete CLDN1 extracellular loop domains using peptide 
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MATERIALS AND METHODS
Cell culture
Human T84 and Caco2 intestinal epithelial cells and HeLa cells were 
cultured in 95% air with 5% CO2 at 37°C. Lentiviral particles encod-
ing shRNA against HIF1β and CLDN1 (MISSION TRC shRNA; Sigma-
Aldrich, St. Louis, MO) were transduced into T84 and Caco2 IECs 
using established protocols. Where indicated, cells were exposed to 
hypoxia in a humidified cell chamber (Coy Laboratory Products, 
Grass Lake, MI) using standard conditions of 1% O2, 5% CO2, 
balance N2.
Transcriptional analysis
TRIzol reagent (Invitrogen, Carlsbad, CA) was used to isolate RNA 
from confluent T84 monolayers. cDNA was reverse transcribed us-
ing the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). PCR 
analysis was performed using SYBR Green (Applied Biosystems, 
Carlsbad, CA) and the primer sequences described in Supplemental 
Table S1.
Western blot analysis
The NE-PER extraction kit was used to prepare nuclear lysates from 
confluent T84 monolayers per manufacturer’s instructions (Thermo 
Scientific, Waltham, MA). Western blotting of these lysates was per-
formed using HIF1β monoclonal mouse antibody (BD Biosciences, 
San Jose, CA) and TATA binding protein monoclonal mouse anti-
body (Abcam, Cambridge, United Kingdom). Western blotting on 
whole-cell lysates was done using rabbit polyclonal anti-CLDN1 
(Invitrogen), polyclonal rabbit anti–β-actin (Abcam), and polyclonal 
antibodies against phosphorylated (Ser-19) and total myosin light 
chain (Cell Signaling Technology, Danvers, MA).
Immunofluorescence and microscopy
T84 or Caco2 cells were grown to confluence on 0.33-cm2, 0.4-μm 
permeable polyester inserts (Corning, Corning, NY), fixed with 2% 
paraformaldehyde, permeabilized with 0.2% Triton X-100, and 
blocked with 5% normal goat serum (NGS). Rb polyclonal antibody 
(pAb) against ZO1 (Invitrogen) was used at 1:100 dilution in 5% 
NGS. Secondary antibody was Alexa Fluor 568 goat anti-rabbit 
(Invitrogen), used at 1:500 dilution in 5% NGS. Immunolabeling was 
visualized with an AxioCam MR c5 attached to an AxioImager A1 
microscope (Zeiss, Oberkochen, Germany). Where indicated, series 
of confocal fluorescence images were obtained using a Zeiss Axio-
vert 200M laser-scanning confocal/multiphoton-excitation fluores-
cence microscope with a Meta spectral detection system (Zeiss NLO 
510 with META; Zeiss, Thornwood, NY) as previously described 
(Dobrinskikh et al., 2013). Quantification of cell area using relative 
pixel values was performed using ImageJ (National Institutes of 
Health, Bethesda, MD).
Calcium switch and permeability assays
T84 cells were grown to confluence on 0.33-cm2, 0.4-μm permeable 
polyester inserts (Corning). Calcium switch was performed by incu-
bating cells in Ca2+-free MEM for suspension culture (S-MEM; Sigma 
Aldrich) with 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid, 14 mM NaHCO3, and 5% dialyzed fetal bovine serum for 16 h. 
Cells were then returned to normal Ca2+ medium. TER was mea-
sured using the EVOM2 voltohmmeter (World Precision Instru-
ments, Sarasota, FL). Paracellular permeability was assayed using a 
FITC-flux assay described previously (Furuta et al., 2001). Briefly, 
confluent T84 monolayers on 0.33-cm2, 0.4-μm permeable polyes-
ter inserts were washed and equilibrated in Hank’s balanced salt 
solution (Sigma-Aldrich). FITC-dextran (Sigma Aldrich), 1 mg/ml, 
mimetics revealed homotypic CLDN1 interactions, as well as a 
close association between CLDN1 and occludin, in the stabilization 
of TJ structure and function (Mrsny et al., 2008). Changes in CLDN1 
expression was found to induce structural and functional changes 
in colon cancer cell lines, promoting an epithelial-mesenchymal 
transition shift in cellular phenotype via altered β-catenin/Tcf sig-
naling (Dhawan et al., 2005). Of interest, TJ structural strand abnor-
malities with selective CLDN1 depletion was described in polar-
ized parotid gland epithelia chronically exposed to the inflammatory 
cytokine interferon γ (IFNγ; Baker et al., 2008). Previous work from 
our group reported a role for IFNγ in mediating repression of HIF1β 
levels and activity, highlighting a potential functional correlation 
between abrogated HIF signaling and IFNγ-regulated CLDN1 loss 
(Glover et al., 2011). In our present model of IEC HIF1β depletion, 
we propose that CLDN1 repression likely abrogates structural ar-
chitecture of the TJ by altering homeostatic head-to-head interac-
tions between junction-associated claudins and occludin. Given 
the loss of lateral membrane in HIF1 KD monolayers, CLDN1 loss 
may further destabilize lateral interactions between claudins within 
a given epithelial cell. Whether IEC β-catenin signaling might 
also be influenced by loss of CLDN1 expression is the subject of 
investigation.
Somewhat surprisingly, we did not observe a difference in epi-
thelial reassembly in HIF1β-deficient cells after Ca2+ switch. 
Whereas the lower baseline TER observed in these cells was main-
tained after assembly, these cells were able to recover from Ca2+ 
switch. It is also noteworthy that CLDN1 expression was induced 
in shNTC and, to a lesser extent, HIF1β-deficient cells during bar-
rier assembly (Figure 3B). We do not know the mechanism(s) of 
such induction. It is possible, for example, that transcription 
factor(s) other than HIF are relatively more important during epi-
thelial barrier establishment. Alternatively, it is possible that the 
increase in CLDN1 protein observed during barrier reassembly is 
not dependent on transcription. This last point is supported, at 
least in part, by the relatively minor induction of CLDN1 mRNA 
during barrier assembly (Figure 3C). Taken together, our results 
strongly implicate HIF-regulated CLDN1 as a central orchestrator 
of TJ homeostasis.
In vivo analysis of CLDN1 expression in intestinal epithelia ob-
tained from WT and conditional HIF1β-null mice revealed no 
baseline difference between the two groups. However, induction 
of experimental colitis using TNBS in these mice resulted in a 
small but nonsignificant increase in CLDN1 in WT mice, with a 
further repression in the conditional HIF1β-null mice. This corre-
lates with defects in in vivo barrier function noted elsewhere 
(Glover et al., 2013) and is consistent with the induction of HIF 
targets seen in other mouse models (Karhausen et al., 2004). 
These data suggest that HIF-mediated expression of CLDN1 
might play an important role in barrier maintenance during an 
inflammatory insult.
HIF has been extensively linked to beneficial outcomes in murine 
models of colitis (Karhausen et al., 2004; Cummins et al., 2008; 
Robinson et al., 2008). Although the endpoints of such signaling 
vary, significant emphasis has been placed on the barrier-protective 
aspects of hypoxia and HIF signaling (Colgan and Taylor, 2010; 
Glover and Colgan, 2011). To date, HIF target genes implicated in 
such barrier protection are more “nonclassical” in nature, including 
intestinal trefoil factor (Furuta et al., 2001), multidrug resistance 
gene (Comerford et al., 2002), mucin-3 (Louis et al., 2006), and 
CD73 (Synnestvedt et al., 2002). The present results provide the first 
evidence that HIF affects barrier function of IECs directly through 
regulation of a TJ component.
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was added to the apical compartment, and samples were taken 
from the basolateral compartment every 30 min for 2 h. Fluores-
cence was determined using a Glomax Multi fluorescent plate 
reader (Promega, Madison, WI) and represented as the change in 
fluorescence over time.
Chromatin immunoprecipitation and promoter experiments
ChIP was performed on confluent Caco2 IECs as previously de-
scribed (Clambey et al., 2012; Glover et al., 2013). Briefly, cells were 
exposed to either normoxia or hypoxia for 6 h and fixed in 1% form-
aldehyde for 10 min at 4°C. Cells were sonicated to shear genomic 
DNA and incubated overnight with 5 μg of either control Rb IgG or 
Rb pAb against HIF1α (NB100-134; Novus Biologicals, Littleton, 
CO). The resulting complexes were precipitated using Fastflow G-
Sepharose beads (GE Healthcare, Little Chalfont, United Kingdom), 
eluted, purified, and analyzed by PCR using HRE spanning primers 
(Supplemental Table S1).
CLDN1 promoter luciferase reporter plasmid (Switchgear 
Genomics, Carlsbad, CA) was mutated using the QuikChange 
Lightning site-directed mutagenesis kit (Agilent Technologies, 
Santa Clara, CA) with primers against both HRE sites. Using Lipo-
fectamine LTX (Invitrogen), 100 ng of plasmid was transfected into 
subconfluent HeLa cells and luciferase activity determined at 24 h 
using LightSwitch luciferase reagent (Switchgear Genomics) and 
luminescence determined using the Glomax Multi plate reader 
(Promega).
CLDN1 overexpression
CLDN1 overexpression plasmid (Thermo Scientific) was transfected 
into subconfluent Caco2 HIF1β KD cells with 5 or 10 μg of plasmid 
on 10-cm dishes using Lipofectamine LTX and Plus reagent per 
manufacturer’s instructions (Invitrogen). Controls were mock trans-
fected. Cells were incubated overnight, trypsinized, and plated on 
0.33-cm2, 0.4-μm polyester inserts (Corning). Monolayers were har-
vested for immunofluorescence at 48 h postplating. Quantification 
of junctional length (A) relative to a straight line between tricellular 
junctions (B) was calculated as a TJ length ratio (equal to A/B) from 
individual image tracings (80 measurements for control, 91 for 5 μg 
of plasmid, and 62 for 10 μg of plasmid transfection) using ImageJ 
(Schneider et al., 2012).
Animals
HIF1β conditional KO mice (Mus musculus) were generated as pre-
viously described (Glover et al., 2013). RNA was isolated from IEC 
HIF1β KO (n = 5) or Cre-negative littermate control (n = 5) whole 
colonic tissue or mucosal scrapings, reverse transcribed, and as-
sayed using PCR. TNBS experimental colitis was induced as 
previously described (Karhausen et al., 2004). Briefly, mice were 
sensitized by epicutaneous administration of 1% TNBS (Sigma Al-
drich) in 80% EtOH on day 0, followed by intrarectal application of 
2.5% TNBS in 50% ethanol on day +7. RNA was isolated from 
whole colonic tissue or mucosal scrapings of duodenum, ileum, 
cecum, and colon, reverse transcribed, and assayed using PCR. All 
animal experiments were reviewed and approved by the Institu-
tional Animal Care and Use Committee at the University of 
Colorado.
Statistical analysis
GraphPad Prism 5 (GraphPad Software, La Jolla, CA) was used to 
generate figures and perform statistical analyses, including paired 
and unpaired t tests. Probability values of p < 0.05 were considered 
statistically significant.
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